Medtronic Recalls Compia MRI CRT-Ds Due to Therapy Prevention Risk
Medtronic is recalling 951 Compia MRI CRT-Ds because a defect may prevent the delivery of high and low voltage therapy.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The source identifies the recall as FDA Class I, which meets the rubric criteria for a Critical severity score.
Plain-English summary
Medtronic Inc. is recalling 951 units of the Compia MRI Cardiac Resynchronization Therapy Defibrillators (CRT-Ds). The affected devices are labeled as Compia MRI CRT-D DF1 (Product No. DTMC1D1) and Compia MRI Quad CRT-D DF4 (Product No. DTMC1QQ). These are implantable devices designed to automatically detect and treat episodes of ventricular fibrillation, ventricular tachycardia, fast ventricular tachycardia, and bradyarrhythmia, with some providing resynchronization therapy.
The recall is issued because of a possible prevention of high and low voltage therapy. This defect could prevent the device from delivering necessary electrical shocks or pacing to treat life-threatening heart rhythms. The devices were distributed nationwide in the United States.
Patients with these specific devices should contact their healthcare provider or Medtronic for instructions on how to proceed. The recall is classified as Class I by the FDA, indicating a reasonable probability that the use of, or exposure to, the violative product will cause serious adverse health consequences or the death.
The recalled product
- Product
- Cardiac Resynchronization Therapy Defibrillators (CRT-Ds), Compia MRI. Labeled as the following: a. Compia MRI CRT-D DF1 (Product No. DTMC1D1); b. Compia MRI Quad CRT-D DF4 (Product No.DTMC1QQ ) Implantable devices that automatically detect and treat episodes of ventric
- Affected units
- 951
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- a. Product No. DTMC1D1: UDI 00643169705807 (Serial No. RPW200289H)
- RPL200534H
- RPL201039H
- RPL201059H
- RPL201235H
- RPL201236H
- RPL201454H
- RPL201645H
- RPL201664H
- RPL201234H)
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 8 recalled by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 8 products in this recall →Related recalls
Same manufacturer · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
See all →- CriticalMedtronic CRT-D Defibrillators: Rare Energy Output Failure Risk During Therapy
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Cardioverter Defibrillators Recalled for Reduced Therapy Output
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Defibrillators Recalled for Potential Therapy Delivery Failure
FDA (Devices) · 2023-06-28
- SevereImplantable Cardioverter Defibrillators at Risk of Reduced Energy Output
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Cardioverter Defibrillator may lose energy output during therapy
FDA (Devices) · 2023-06-28
Same hazard · therapy prevention
See all →- SevereMedtronic Recalls Claria MRI CRT-Ds Due to Therapy Prevention Risk
FDA (Devices) · 2018-02-28
- CriticalMedtronic Recalls Evera ICDs Due to Possible Therapy Prevention
FDA (Devices) · 2018-02-28
- HighMedtronic Recalls 951 Evera MRI ICDs Due to Therapy Prevention Risk
FDA (Devices) · 2018-02-28
- HighMedtronic Recalls Visia AF MRI ICDs Due to Therapy Prevention Risk
FDA (Devices) · 2018-02-28